Isolation end purification of superbins I and II from Austrelaps superbus (copperiieab) snake venom and their anticoagulant and antiplatelet effects

Toxicon

Volumn 35, Issue 8, 1997, Pages 1239-1250

  Subburaju, S ^a   Kini, R Manjunatha ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

SNAKE VENOM; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; PHOSPHOLIPASE A; PROTEIN;

ARTICLE; BLOOD CLOTTING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTHROMBIN TIME; PURIFICATION; THROMBOCYTE AGGREGATION; TOXIN ANALYSIS; TOXIN STRUCTURE; BLOOD CLOTTING TEST; CHEMISTRY; ENZYMOLOGY; ISOLATION AND PURIFICATION; MOLECULAR WEIGHT;

ANTICOAGULANTS; BLOOD COAGULATION TESTS; CROTALID VENOMS; HUMANS; MOLECULAR WEIGHT; PHOSPHOLIPASES A; PLATELET AGGREGATION INHIBITORS; PROTEINS;

EID: 0030610957     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(97)00014-7     Document Type: Article

References (35)

1. Basheer, A. R., El-Asmar, M. F. and Soslau, G. (1995) Characterization of a potent platelet aggregation inducer from Cerastes cerastes (Egyptian sand viper) venom. Biochimica et Biophysica Acta 1250, 97-109.
2. 2 with anticoagulant actvity. II. Inhibition of the phospholipid activity in coagulation. Biochimica et Biophysica Acta 429, 839-852.
3. 2 with anticoagulant activity. I. Isolation from Vipera berus venom and properties. Biochimica et Biophysica Acta 429, 828-838.
4. 2. In Natural Toxins, ed. D. Eaker and T. Wadström, pp. 131-138. Pergamon Press, Oxford.
5. Cardinal, D. C. and Flower, R. J. (1980) The electronic aggregometer: a novel device for assessing platelet behaviour in blood. Journal of Pharmacological Methods 3, 135-158.
6. 2. Journal of Biological Chemistry 255, 3793-3797.
7. Hutton, R. A. and Warrel, D. A. (1993) Action of snake venom components on the haemostatic system. Blood Review 7, 176-189.
8. Kamiguti, A. S. and Sano-Martins, I. S. (1995) South American snake venom affecting haemostasis. Journal of Toxicology 14, 359-374.
9. Kamiguti, A. S., Sousa E Silva, M. C. C., Morena, P. and Nahas, L. (1985) The anticoagulant effect of Bothrops castelnaudi snake venom (Castelnaud's pit viper). Toxicon 23, 383-391.
10. Kawauchi, S., Iwanaga, S., Samejima, Y. and Suzuki, T. (1970) Isolation and characterization of two phospholipase As from the venom of Agkistrodon halys blomhoffii. Biochimica et Biophysica Acta 236, 142-160.
11. 2. Journal of Biological Chemistry 262, 402-414.
12. 2 isoenzymes from Naja nigricollis venom. Thrombosis and Haemostasis 60, 170-173.
13. 2. Toxicon 27, 613-635.
14. Kini, R. M. and Evans, H. J. (1990) Effects of snake venom proteins on blood platelets. Toxicon 28, 1387-1422.
15. 2 isoenzymes from Naja nigricollis venom. Toxicon 33, 1585-1590.
16. 2 Enzymes: Structure, Function and Mechanism, ed. R. M. Kini, pp. 369-387. Wiley, Chichester.
17. Li, Y. S., Liu, K. F., Wang, Q. C., Ran, Y. L. and Tu, G. C. (1985) A platelet function inhibitor purified from Vipera russelli siamensis (Smith) snake venom. Toxicon 23, 895-903.
18. Marshall, L. R. and Herrmann, R. P. (1983) Coagulant and anticoagulant actions of Australian snake venoms. Thrombosis and Haemostasis 50, 707-711.
19. Marshall, L. R. and Herrmann, R. P. (1989) Australian snake venoms and their in vitro effect on human platelets. Thrombosis Research 54, 269-275.
20. Ouyang, C. and Huang, T. F. (1983) Potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Biochimica et Biophysica Acta 757, 332-341.
21. Ouyang, C., Jy, W., Zan, Y. P. and Teng, C. M. (1981) Mechanism of the anticoagulant action of phospholipase A purified from Trimeresurus mucrosquamatus (Formosan habu) snake venom. Toxicon 19, 113-120.
22. Ouyang, C., Teng, C. M. and Huang, T. F. (1992) Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 30, 945-966.
23. Pitlick, F. A. and Nemerson, Y. (1970) Binding of the protein component of tissue factor to phospholipids. Biochemistry 9, 5105-5113.
24. Quick, A. J. (1966) Prothrombin time (one-stage procedure). In Hemorragic Diseases and Thrombosis, ed. A. J. Quick, 2nd edn, pp. 391-396. Eea and Febiger, Philadelphia, PA.
25. Roepstorff, P. (1993) Mass spectrometry of proteins. Trends in Analytical Chemistry 12, 413-421.
26. Rosing, J. and Tans, G. (1992) Structural and functional properties of snake venom prothrombin activators. Toxicon 30, 1515-1527.
27. Scarborough, R. M., Naughton, M. A., Teng, W., Rose, J. W., Phillips, D. R., Nannizzi, L., Arfsten, A., Campbell, A. M. and Charo, I. F. (1993) Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. Journal of Biological Chemistry 268, 1066-1073.
28. Sekiya, F., Atoda, H. and Morita, T. (1993) Isolation and characterization of an anticoagulant protein homologous to botrocetin from the venom of Bothrops jararaca. Biochemistry 32, 6892 6897.
29. 2 isoenzymes from Naja nigricollis venom. Thrombosis Research 55, 481-491.
30. 2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism. Biochemistry 29, 7742-7746.
31. Teng, C. M., Chen, Y. F. and Ouyang, C. (1984) Biphasic effect of on platelet aggregation by phospholipase A purified from Vipera russellii snake venom. Biochimica et Biophysica Acta 772, 393-402.
32. 2. European Journal of Biochemistry 112, 25-32.
33. Williams, W. J. and Esnouf, M. P. (1962) The fractionation of Russell's-viper (Vipera russelii) venom with special reference to the coagulant protein. Biochemical Journal 84, 52-62.
34. 2: a potent inhibitor of platelet aggregation. Thrombosis Research 70, 471-481.
35. 2. Blood 86, 4166-4174.